Table of Content
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product Type
3.2. Market Snippet by Indication
3.3. Market Snippet by Age
3.4. Market Snippet by End user
3.5. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Innovative technologies in the endovascular treatment of abdominal aortic aneurysms are expected to drive market growth.
4.1.2. Restraints:
4.1.2.1. The inflated cost of EVAR procedures compared to open surgeries is expected to hamper the market growth.
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Reimbursement Analysis
5.4. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Fenestrated EVAR*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Adjunctive Stent Graft
7.4. Branched Stent Graft
7.5. Others
8. By Indication
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
8.1.2. Market Attractiveness Index, By Indication Segment
8.2. Abdominal Aortic Aneurysm (AAA)*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Thoracic Aortic Aneurysm (TAA)
8.4. Thoracoabdominal Aortic Aneurysm (TAAA)
8.5. Others
9. By Age
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
9.1.2. Market Attractiveness Index, By Age Segment
9.2. Pediatric*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Adult
9.4. Geriatric
10. By End user
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
10.1.2. Market Attractiveness Index, By End user Segment
10.2. Hospital*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Ambulatory Surgery Centers
10.4. Clinics
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Age
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch
13. Company Profiles
13.1. Cardinal Health*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Lombard Medical Limited
13.3. Endologix Inc.
13.4. Terumo Corporation
13.5. MicroPort Scientific Corporation
13.6. JOTEC GmbH
13.7. W. L. Gore & Associates, Inc.
13.8. Cook Group Incorporated
13.9. Medtronic plc (*LIST NOT EXHAUSTIVE*)
14. DataM Intelligence
14.1. Appendix
14.2. About Us
14.3. Contact Us